36 research outputs found
Video-assisted thoracic surgery (VATS) as a safe alternative for the resection of pulmonary metastases: a retrospective cohort study
<p>Abstract</p> <p>Background</p> <p>VATS has become a preferred method for benign surgical conditions, yet still remains controversial for malignancies. The purpose of this study was to review our results of pulmonary metastasectomies using both conventional open thoracotomy and VATS techniques.</p> <p>Methods</p> <p>This is a retrospective chart review of pulmonary metastasectomies performed from 1986 to 2006. The surgical approach used for the initial pulmonary metastasectomy was either open thoracotomy or VATS. Main outcomes were overall survival and recurrence free survival, evaluated using Kaplan Meier analysis. A non-inferiority margin was set at 0.2.</p> <p>Results</p> <p>A total of 280 surgical procedures were performed on 186 patients. From 171 eligible individuals, 135 patients were treated with thoracotomy (82 M, 53 F; median age 49 years), and 36 with VATS (18 M, 18 F; median age 58.5 years). Primary cancers were mainly: 81 sarcoma (47%), 26 colorectal adenocarcinoma (15%) and 22 renal cell carcinoma (13%). Median postoperative follow was 26.2 months. The conversion rate was 10.3% and there were no cases of pleural cavity seeding. The 5-year overall survival rates were 58.8% for thoracotomy and 69.6% for VATS, with median overall survival of 53.2 months and 30.1 months, respectively (p = 0.03). The estimated difference in 5-year overall survival was 10.8%. Second occurrences were noted in 59 thoracotomy and 10 VATS patients. The 5-year recurrence free survival rates were 51% in thoracotomy and 67% in VATS (p = 0.27), with median recurrence free survival of 24.8 months and 25.6 months, respectively.</p> <p>Conclusion</p> <p>In cases of pulmonary metastases, VATS is an acceptable alternative that is both safe and efficacious. Non-inferiority analysis of 5-year overall survival demonstrates that VATS is equivalent to thoracotomy. VATS patients also have a longer recurrence free survival. Based on our experience, it is permissible to use VATS resection in these circumstances: small tumor, fewer nodules, single lesion, age ≤ 53, unilateral, tumor size amenable to wedge resection, and non-recurrent disease.</p
Video-assisted thoracic surgery (VATS) for resection of metastatic adenocarcinoma as an acceptable alternative
Adenocarcinomas commonly metastasize to the lungs and can be resected using open thoracotomy or video-assisted thoracic surgery (VATS). This study reviews metastatic resections in primary adenocarcinoma patients, using both thoracotomy and VATS. We aim to compare long-term prognoses to test the efficacy and viability of VATS.
A retrospective review of primary adenocarcinoma patients who underwent resection of pulmonary metastases from 1990 to 2006 was carried out. Information was obtained by chart review. Endpoints analyzed were disease-free interval (DFI), survival time, and recurrence-free survival (RFS).
In a total of 42 (16 male, 26 female; median age 58.5 years) primary adenocarcinoma patients, 21 patients underwent first pulmonary metastatic resection using VATS (7 male, 14 female; median age 57 years) and 21 using thoracotomy (9 male, 12 female; median age 59 years). Primary adenocarcinomas were mainly 27 colorectal (64%) and 11 breast (26%). Two VATS (10%) and three open patients (14%) had local recurrences of the original cancer. Median postoperative follow was 13.3 months [interquartile range (IQR) 4.5–32.8 months] for VATS and 36.9 months (IQR 19.3–48.6 months) after thoracotomy. Median DFI–1 was 22.3 months (IQR 13.5–40.6 months) for VATS patients and 35.6 months (IQR 26.7–61.3 months) for open patients. Second thoracic occurrences were noted in six VATS patients (median DFI–2 9.2 months), and in seven open patients (median DFI-2 21.5 months). Third thoracic occurrences were noted in one VATS patient (DFI-3 18.7 months) and in one thoracotomy patient (DFI-3 21.8 months). Odds ratio of recurrence showed 12.5% less chance of developing recurrence in VATS patients. Five-year RFS was 53% in VATS and 57% in thoracotomy patients.
VATS has become a viable alternative to open thoracotomy for resection of pulmonary metastases. In cases of primary adenocarcinoma, VATS showed no increase in number of thoracic recurrences, and comparable RFS. Short-term follow-up is encouraging; long-term follow-up will be needed to confirm these results
Minimally invasive surgery and cancer: controversies part 1
Perhaps there is no more important issue in the care of surgical patients than the appropriate use of minimally invasive surgery (MIS) for patients with cancer. Important advances in surgical technique have an impact on early perioperative morbidity, length of hospital stay, pain management, and quality of life issues, as clearly proved with MIS. However, for oncology patients, historically, the most important clinical questions have been answered in the context of prospective randomized trials. Important considerations for MIS and cancer have been addressed, such as what are the important immunologic consequences of MIS versus open surgery and what is the role of laparoscopy in the staging of gastrointestinal cancers? This review article discusses many of the key controversies in the minimally invasive treatment of cancer using the pro–con debate format
Diagnostic performance of a CT-based scoring system for diagnosis of anastomotic leakage after esophagectomy: comparison with subjective CT assessment
Rationale and study design for an individualized perioperative open lung ventilatory strategy (iPROVE): study protocol for a randomized controlled trial
Recommended from our members
Geothermal Drilling Research in the United States
The high cost of drilling and completing geothermal wells is an impediment to the development of this resource. The Department of Energy (DOE), Division of Geothermal Energy (DGE), is conducting an R and D program directed at reducing well costs through improvements in geothermal drilling and completion technology. This program includes R and D activities in high temperature drilling hardware, drilling fluids, lost circulation control methods, completion technology, and advanced drilling systems. An overview of the program is presented
Recommended from our members
Joint DOE/Industry Photovoltaic System Reliability Program
To achieve the lowest life-cycle cost (LCC), photovoltaic (PV) systems must have the optimum mix of low first cost, low operation and maintenance (O&M) cost, and high availability. Additionally, the long-term health of the photovoltaic (PV) industry requires that PV systems work as expected. Although PV modules now enjoy high reliability due to a significant multi-year effort by both the U.S. Department of Energy (DOE) and industry, the same is not always true of PV systems. Even for systems that do operate reliably, customers, suppliers, and manufacturers can benefit from knowing what O&M expenses to expect. This knowledge will reduce technology risk to the customer and improve likelihood of commitment to PV projects. System integrators and utilities may benefit from O&M cost information to improve system designs, to properly price service agreements and warranties, and to optimize maintenance strategies. The DOE and component manufacturers may benefit from identifying cost drivers to optimally focus research and quality assurance resources to improve product reliability. This paper discusses the first of five tasks identified for this project, quantifying system reliability and life cycle cost by collecting, analyzing and reporting data on PV system reliability and cost. Industry participants collect the necessary O&M data on systems they are monitoring. Sandia provides support in the form of assistance identifying data that needs to be collected, helping develop forms or databases to collect the data, and analyzing the data
Recommended from our members
Solartrak{trademark} Controller Developments for Today's Applications
The SolarTrak{trademark} array tracking controller, originally developed and licensed by Sandia National Laboratories as a low-cost, high-accuracy, reliable controller for photovoltaic (PV) concentrator arrays, has undergone significant development to make tracking accessible to a much broader segment of the PV market. Hardware and software improvements (1) reduce power consumption for PV/battery- powered applications, (2) enable the controller to connect directly with low-cost, off-the-shelf, television satellite dish actuators, (3) enable on-site setup without an additional input board, (4) increase clock accuracy by providing daily and weekly adjustments to the on board clock, and (5) include a low-cost wind stow sensor. The result is a stand-alone tracking system sufficiently low cost and reliable to make 1-kW tracking systems practical for flat plate and concentrating arrays. Results of a year of testing are presented showing clock accuracy better than a minute per year can be maintained
Recommended from our members
Video-assisted thoracic surgery (VATS) for resection of metastatic adenocarcinoma as an acceptable alternative
Adenocarcinomas commonly metastasize to the lungs and can be resected using open thoracotomy or video-assisted thoracic surgery (VATS). This study reviews metastatic resections in primary adenocarcinoma patients, using both thoracotomy and VATS. We aim to compare long-term prognoses to test the efficacy and viability of VATS.
A retrospective review of primary adenocarcinoma patients who underwent resection of pulmonary metastases from 1990 to 2006 was carried out. Information was obtained by chart review. Endpoints analyzed were disease-free interval (DFI), survival time, and recurrence-free survival (RFS).
In a total of 42 (16 male, 26 female; median age 58.5 years) primary adenocarcinoma patients, 21 patients underwent first pulmonary metastatic resection using VATS (7 male, 14 female; median age 57 years) and 21 using thoracotomy (9 male, 12 female; median age 59 years). Primary adenocarcinomas were mainly 27 colorectal (64%) and 11 breast (26%). Two VATS (10%) and three open patients (14%) had local recurrences of the original cancer. Median postoperative follow was 13.3 months [interquartile range (IQR) 4.5–32.8 months] for VATS and 36.9 months (IQR 19.3–48.6 months) after thoracotomy. Median DFI–1 was 22.3 months (IQR 13.5–40.6 months) for VATS patients and 35.6 months (IQR 26.7–61.3 months) for open patients. Second thoracic occurrences were noted in six VATS patients (median DFI–2 9.2 months), and in seven open patients (median DFI-2 21.5 months). Third thoracic occurrences were noted in one VATS patient (DFI-3 18.7 months) and in one thoracotomy patient (DFI-3 21.8 months). Odds ratio of recurrence showed 12.5% less chance of developing recurrence in VATS patients. Five-year RFS was 53% in VATS and 57% in thoracotomy patients.
VATS has become a viable alternative to open thoracotomy for resection of pulmonary metastases. In cases of primary adenocarcinoma, VATS showed no increase in number of thoracic recurrences, and comparable RFS. Short-term follow-up is encouraging; long-term follow-up will be needed to confirm these results